2023
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA et. al.Základní údaje
Originální název
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
Autoři
SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA, Martin PEC, Olga GOLUBNITSCHAJA, Raghad Khalid AL-ISHAQ, Martin CAPRNDA, Ludovit GASPAR, Robert PROSECKÝ (203 Česká republika, domácí), Katarina GAZDIKOVA, Mariusz ADAMEK, Dietrich BUESSELBERG, Peter KRUŽLIAK (703 Slovensko, garant, domácí) a Peter KUBATKA
Vydání
European Journal of Pharmacology, AMSTERDAM, Elsevier, 2023, 0014-2999
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.000 v roce 2022
Kód RIV
RIV/00216224:14110/23:00131597
Organizační jednotka
Lékařská fakulta
UT WoS
001053815500001
Klíčová slova anglicky
Flavonoids; Cancer cells; Carcinogenesis; Metabolism; Metabolic reprogramming
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 9. 2023 10:47, Mgr. Tereza Miškechová
Anotace
V originále
Metabolic reprogramming of cancer cells is a common hallmark of malignant transformation. The preference for aerobic glycolysis over oxidative phosphorylation in tumors is a well-studied phenomenon known as the Warburg effect. Importantly, metabolic transformation of cancer cells also involves alterations in signaling cascades contributing to lipid metabolism, amino acid flux and synthesis, and utilization of ketone bodies. Also, redox regulation interacts with metabolic reprogramming during malignant transformation. Flavonoids, widely distributed phytochemicals in plants, exert various beneficial effects on human health through modulating molecular cascades altered in the pathological cancer phenotype. Recent evidence has identified numerous flavonoids as modulators of critical components of cancer metabolism and associated pathways interacting with metabolic cascades such as redox balance. Flavonoids affect lipid metabolism by regulating fatty acid synthase, redox balance by modulating nuclear factor-erythroid factor 2-related factor 2 (Nrf2) activity, or amino acid flux and synthesis by phosphoglycerate mutase 1. Here, we discuss recent preclinical evidence evaluating the impact of flavonoids on cancer metabolism, focusing on lipid and amino acid metabolic cascades, redox balance, and ketone bodies.